Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Valpromide

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Valproic Acid - Scientific conclusions and new Authorisation terms in Europe
    Valproic Acid - Scientific conclusions and new Authorisation terms in Europe

    25 Oct 2018

    // EMA

    https://www.ema.europa.eu/documents/psusa-conclusions/valproic-acid-sodium-valproate-valproate-pivoxil-valproate-semisodium-valpromide-cmdh-scientific/00003090/201801_en.pdf

    EMA
    25 Oct 2018
    Share Share
    Valproic Acid - List of nationally authorised medicinal products in Europe
    Valproic Acid - List of nationally authorised medicinal products in Europe

    25 Oct 2018

    // EMA

    https://www.ema.europa.eu/documents/psusa-products/valproic-acid-sodium-valproate-valproate-pivoxil-valproate-semisodium-valpromide-valproate-bismuth/00003090/201801_en.pdf

    EMA
    25 Oct 2018
    Share Share
    New review of valproate use in pregnancy and women of childbearing age
    New review of valproate use in pregnancy and women of childbearing age

    11 Apr 2017

    // EMA

    http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/referrals/Valproate_and_related_substances/human_referral_prac_000066.jsp&mid=WC0b01ac05805c516f

    EMA
    11 Apr 2017
    Share Share